{
    "root": "30b59e04-dc7a-17c6-e063-6394a90ad264",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metformin Hydrochloride",
    "value": "20250319",
    "ingredients": [
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "POVIDONE K90",
            "code": "RDH86HJV5Z"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "BLACKBERRY",
            "code": "8A6OMU3I8L"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METFORMIN HYDROCHLORIDE",
            "code": "786Z46389E"
        }
    ],
    "indications": "metformin hydrochloride tablets indicated adjunct diet exercise improve glycemic control adults pediatric patients 10 years age older type 2 diabetes mellitus .",
    "contraindications": "adult metformin hydrochloride tablets : starting dose : 500 mg orally twice day 850 mg day , meals ( 2.1 ) increase dose increments 500 mg weekly 850 mg every 2 weeks , maximum dose 2550 mg per day , given divided doses ( 2.1 ) doses 2000 mg may better tolerated given 3 times day meals ( 2.1 ) pediatric metformin hydrochloride tablets : starting dose : 500 mg orally twice day , meals ( 2.2 ) increase increments 500 mg weekly maximum 2000 mg per day , given divided doses twice daily ( 2.2 ) renal impairment : prior initiation , assess renal function estimated glomerular filtration rate ( egfr ) ( 2.3 ) patients egfr 30 ml/minute/1.73 2 ( 2.3 ) initiation recommended patients egfr 30 45 ml/minute/1.73 2 ( 2.3 ) assess risk/benefit continuing egfr falls 45 ml/minute/1.73 2 ( 2.3 ) discontinue egfr falls 30 ml/minute/1.73 2 ( 2.3 )",
    "warningsAndPrecautions": "metformin hydrochloride tablets , 1000 mg usp white off-white , oval , biconvex , scored , film coated tablets debossing g 12 one either sides score line plain side . ndc : 70518-3101-00 ndc : 70518-3101-01 ndc : 70518-3101-02 ndc : 70518-3101-03 ndc : 70518-3101-04 ndc : 70518-3101-05 ndc : 70518-3101-06 packaging : 30 1 blister pack packaging : 180 1 bottle plastic packaging : 90 1 bottle plastic packaging : 30 1 blister pack packaging : 30 1 blister pack packaging : 60 1 bottle plastic packaging : 100 1 bottle plastic store 20\u00ba 25\u00ba c ( 68\u00ba 77\u00ba f ) ; excursions permitted 15\u00ba 30\u00ba c ( 59\u00ba 86\u00ba f ) . [ usp controlled room temperature . ] dispense tight , light-resistant containers child-resistant closure . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "metformin hydrochloride tablets contraindicated patients : severe renal impairment ( egfr 30 ml/min/1.73 2 ) [ ( 5.1 ) ] . hypersensitivity metformin . acute chronic metabolic acidosis , including diabetic ketoacidosis , without coma .",
    "indications_original": "Metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.",
    "contraindications_original": "Adult Dosage for metformin hydrochloride tablets: Starting dose: 500 mg orally twice a day or 850 mg once a day, with meals ( 2.1 ) Increase the dose in increments of 500 mg weekly or 850 mg every 2 weeks, up to a maximum dose of 2550 mg per day, given in divided doses ( 2.1 ) Doses above 2000 mg may be better tolerated given 3 times a day with meals ( 2.1 ) Pediatric Dosage for metformin hydrochloride tablets: Starting dose: 500 mg orally twice a day, with meals ( 2.2 ) Increase dosage in increments of 500 mg weekly up to a maximum of 2000 mg per day, given in divided doses twice daily ( 2.2 ) Renal Impairment: Prior to initiation, assess renal function with estimated glomerular filtration rate (eGFR) ( 2.3 ) Do not use in patients with eGFR below 30 mL/minute/1.73 m 2 ( 2.3 ) Initiation is not recommended in patients with eGFR between 30 to 45 mL/minute/1.73 m 2 ( 2.3 ) Assess risk/benefit of continuing if eGFR falls below 45 mL/minute/1.73 m 2 ( 2.3 ) Discontinue if eGFR falls below 30 mL/minute/1.73 m 2 ( 2.3 )",
    "warningsAndPrecautions_original": "Metformin hydrochloride Tablets, 1000 mg USP White to off-white, oval, biconvex, scored, film coated tablets debossing G and 12 on one either sides of the score line and plain on the other side.\n                  \n                  NDC: 70518-3101-00\n                  NDC: 70518-3101-01\n                  NDC: 70518-3101-02\n                  NDC: 70518-3101-03\n                  NDC: 70518-3101-04\n                  NDC: 70518-3101-05\n                  NDC: 70518-3101-06\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 180 in 1 BOTTLE PLASTIC\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 100 in 1 BOTTLE PLASTIC\n                  \n                  \n                  Store at 20\u00ba to 25\u00ba C (68\u00ba to 77\u00ba F); excursions permitted to 15\u00ba to 30\u00ba C (59\u00ba to 86\u00ba F). [see USP Controlled Room Temperature.]\n                  \n                  \n                  Dispense in tight, light-resistant containers with child-resistant closure.\n                  \n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Metformin hydrochloride tablets are contraindicated in patients with:\n                  \n                     Severe renal impairment (eGFR below 30 mL/min/1.73 m\n  \n   2) [\n  \n   \n                           see Warnings and Precautions (5.1)\n                        ].\n \n  \n                     Hypersensitivity to metformin.\n                     Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma."
}